Feasibility of serum galactomannan assay in hematologic malignancy patients with invasive fungal infections

Journal of Leukemia and Lymphoma

Volumn 19, Issue 7, 2010, Pages 427-431

  Leng, Yun ^a   Li, Li Hong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Galactomannan assay; Hematologic malignancy; Hematologic neoplasms; Invasive fungal infections; Sensitivity and specificity

Indexed keywords

GALACTOMANNAN;

ADULT; AGED; ARTICLE; ASSAY; BACTERIAL INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEASIBILITY STUDY; FEMALE; FEVER; HEMATOLOGIC MALIGNANCY; HIGH RISK PATIENT; HUMAN; KAPPA STATISTICS; MALE; MYCOSIS; SENSITIVITY AND SPECIFICITY; SERUM GALACTOMANNAN ASSAY;

EID: 77955698223     PISSN: 10099921     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1009-9921.2010.07.015     Document Type: Article

References (18)

1. Singh N, David L. Patersonet.Aspergillus Infections in transplant recipients. Clin Microbiol Rev, 2005,18:44-69.
2. Walsh T, Sable C, de Pauw B, et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med, 2004,351:1391-1402.
3. Pagano L, Caira M, Candoni A, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica, 2006,91:1068-1075.
4. Khan ZU, Ahmad S, Theyyathel AM. Detection of Aspergillus fumigatus-specific DNA, (1-3)-β-D-glucan and galactomannan in serum and bronchoalveolar lavage specimens of experimentally infected rate. Mycoses, 2008,51:129-135.
5. Caillot D, Couaillier JF, Bernard A, et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol, 2001,19:253-259.
6. Kersten MA, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis, 2004,4:349-357. (Pubitemid 38692699)
7. Pazos C, Del Palacio A. Early diagnosis of invasive aspergillosis in neutropenic patients with bi-weekly serial screening of circulating galactomannan by Platelia Aspergillus. Rev Iberoam Micol, 2003, 20: 99-102.
8. Pfeiffer CH, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis, 2006, 42: 1428-1430.
9. Wheat LJ. Galactomannan Antigenemia Detection for Diagnosis of Invasive Aspergillosis, Part I. Clin Microbiol Newsl, 2005,27:51-57.
10. Adam O, Aup é rin A, Wilquin F, et al. Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clin Infect Dis, 2004,38:917-920.
11. Aubry A, Porcher R, Bottero J, et al. Occurrence and kinetics of false- positive Aspergillus galactomannan test results following treatment with? Lactam antibiotics in patients with hematological disorders. J Clin Microbiol, 2006,44:389-394. (Pubitemid 43222228)
12. Pazos C, Del Palacio A. Early diagnosis of invasive aspergillosis in neutropenic patients with bi-weekly serial screening of circulating galactomannan by Platelia Aspergillus. Rev Iberoam Micol, 2003,20:99-102.
13. Mennink-Kersten MA, Klont RR, Warns A, et al. Bifidobacterium lipoteichoic acid and false ELISA reactivity in Aspergillus antigen detection. Lancet, 2005,363:325-327.
14. Racil Z, Kocmanova I, Lengerova M, et al. Intravenous PLASMA-LYTE as a major cause of false-positive results of platelia aspergillus test for galactomannan detection in serum. J Clin Microbiol, 2007,45:3141-3142. (Pubitemid 47417379)
15. Maertens J, van Eldere J, Verhaegen J, et al. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis, 2002,186:1297-1306. (Pubitemid 35193008)
16. Boutboul F, Alberti C, Leblanc T, et al. Invasive aspergillosis in allogeneic stem cell transplantrecipients: increasing antigenemia is associated with progressive disease. Clin Infect Dis, 2002,34:939-943. (Pubitemid 34229762)
17. Miceli MH, Maertens J, Buve K, et al. Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implications. Cancer, 2007,110:112-120.